These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 18202794)
21. Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 study. Lesimple T; Riffaud L; Frappaz D; Ben Hassel M; Gédouin D; Bay JO; Linassier C; Hamlat A; Piot G; Fabbro M; Saïkali S; Carsin B; Guégan Y J Neurooncol; 2009 Jun; 93(2):253-60. PubMed ID: 19139825 [TBL] [Abstract][Full Text] [Related]
22. A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies. Paik PK; Rudin CM; Brown A; Rizvi NA; Takebe N; Travis W; James L; Ginsberg MS; Juergens R; Markus S; Tyson L; Subzwari S; Kris MG; Krug LM Cancer Chemother Pharmacol; 2010 Nov; 66(6):1079-85. PubMed ID: 20165849 [TBL] [Abstract][Full Text] [Related]
23. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425 [TBL] [Abstract][Full Text] [Related]
24. Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer. Ge XH; Lin Q; Ren XC; Liu YE; Chen XJ; Wang DY; Wang YQ; Cao B; Li ZG; Liu ML Radiat Oncol; 2013 Oct; 8():238. PubMed ID: 24125485 [TBL] [Abstract][Full Text] [Related]
25. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. Langer CJ; Ruffer J; Rhodes H; Paulus R; Murray K; Movsas B; Curran W Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):113-9. PubMed ID: 11516860 [TBL] [Abstract][Full Text] [Related]
26. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer. Miller AA; Al Omari A; Murry DJ; Case D Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403 [TBL] [Abstract][Full Text] [Related]
27. A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies. Forouzannia A; Schiller J; Berlin J; Hutson P; Boothman D; Storer B; Wilding G; Mehta M Lung Cancer; 2004 Apr; 44(1):111-9. PubMed ID: 15013589 [TBL] [Abstract][Full Text] [Related]
28. Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme. Moyal EC; Laprie A; Delannes M; Poublanc M; Catalaa I; Dalenc F; Berchery D; Sabatier J; Bousquet P; De Porre P; Alaux B; Toulas C Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1396-401. PubMed ID: 17570606 [TBL] [Abstract][Full Text] [Related]
29. Topotecan as a 21-day continuous infusion with accelerated 3D-conformal radiation therapy for patients with glioblastoma. Grabenbauer GG; Buchfelder M; Schrell U; Fahlbusch R; Sauer R; Staab HJ Front Radiat Ther Oncol; 1999; 33():364-8. PubMed ID: 10549508 [No Abstract] [Full Text] [Related]
30. Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen. Hochster H; Liebes L; Speyer J; Sorich J; Taubes B; Oratz R; Wernz J; Chachoua A; Raphael B; Vinci RZ J Clin Oncol; 1994 Mar; 12(3):553-9. PubMed ID: 8120553 [TBL] [Abstract][Full Text] [Related]
31. Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol. Lotz JP; Pautier P; Selle F; Viens P; Fabbro M; Lokiec F; Viret F; Gligorov J; Gosse B; Provent S; Ribrag V; Micléa JM; Dosquet C; Goetschel A; Cailliot C; Lefèvre G; Genève J; Lhommé C; Bone Marrow Transplant; 2006 Apr; 37(7):669-75. PubMed ID: 16501591 [TBL] [Abstract][Full Text] [Related]
32. A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer. Garst J; Herndon JE; Shafman T; Campagna L; Blackwell S; Padilla K; Bjurstrom T; Andrews C; Maravich-May D; Anderson E; Crawford J Clin Drug Investig; 2006; 26(5):257-66. PubMed ID: 17163259 [TBL] [Abstract][Full Text] [Related]
33. A phase I trial of a 3-day topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneum. Brown JV; Peters WA; Rettenmaier MA; Karlan BY; Dillman RA; Smith MR; Drescher CW; Micha JP Gynecol Oncol; 2000 Dec; 79(3):495-8. PubMed ID: 11104627 [TBL] [Abstract][Full Text] [Related]
34. A phase I study of weekly topotecan and Paclitaxel in previously treated epithelial ovarian carcinoma patients. Homesley H; Benigno B; Williams J; Vaccarello L Gynecol Oncol; 2002 Nov; 87(2):171-7. PubMed ID: 12477447 [TBL] [Abstract][Full Text] [Related]
35. Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases. Mirmiran A; McClay E; Spear MA Med Oncol; 2007; 24(2):147-53. PubMed ID: 17848737 [TBL] [Abstract][Full Text] [Related]
36. Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide. Herben VM; ten Bokkel Huinink WW; Dubbelman AC; Mandjes IA; Groot Y; van Gortel-van Zomeren DM; Beijnen JH Br J Cancer; 1997; 76(11):1500-8. PubMed ID: 9400949 [TBL] [Abstract][Full Text] [Related]
37. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial. Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701 [TBL] [Abstract][Full Text] [Related]
38. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651 [TBL] [Abstract][Full Text] [Related]
39. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes. Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N Chemotherapy; 2005 May; 51(2-3):154-61. PubMed ID: 15886476 [TBL] [Abstract][Full Text] [Related]
40. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial. Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]